DESCRIPTION OF CLINICAL, PARACLINICAL FEATURES AND PREGNANCY RATE OF PATIENTS WHO RESPOND POORLY TO OVARIAN STIMULATION
Main Article Content
Abstract
Objectives: To describe the clinical and paraclinical characteristics and comment on the number of oocytes and the pregnancy rate of patients who have a poor ovarian response to ovarian stimulation. Subjects and methods: A cross-sectional descriptive study of 60 cases of poor response to ovarian stimulation who were examined and treated at the National Center for Assisted Reproductive Technology - National Hospital of Obstetrics and Gynecology from January 2021 to September 2021. Results and discussion: The poor response to ovarian stimulation was mainly in elderly patients with a mean age of 36,78 ± 4,95 years and a relatively long duration of infertility of 5,00 ± 2,87 years. The patients who responded poorly to ovarian stimulation exhibited a low mean AMH index of 1,04 ± 0,82 ng/ml and a low number of secondary follicles of 5,57 ± 1,48 follicles. The average number of oocytes retrieved was 5,10 ± 2,27. In which the number of MII oocytes accounted for the most with 4,23 ± 1,89. The proportion of patients who tested positive for hCG was 13,56%. The clinical pregnancy rate is 10,17%. The ongoing pregnancy rate was 8,47%. Stillbirth rate: the control group had 1 case of stillbirth, accounting for 1,67%. The biochemical pregnancy rate with 2 cases of biochemical pregnancy accounted for 3,39%.
Article Details
Keywords
Poor response, ovarian stimulation, in vitro fertilization
References
2. Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction. 2011; 26(7):1616-1624. doi:10.1093/humrep/der092
3. Nguyễn Thị Ngọc Phượng. Nội tiết sinh sản nữ: cơ chế tác động và điều hòa. In: Nội Tiết Sinh Sản.; 2011:27-34.
4. Kim CH, Ahn JW, Moon JW, Kim SH, Chae HD, Kang BM. Ovarian Features after 2 Weeks, 3 Weeks and 4 Weeks Transdermal Testosterone Gel Treatment and Their Associated Effect on IVF Outcomes in Poor Responders. Dev Reprod. 2014; 18(3):145-152. doi:10.12717/DR.2014.18.3.145
5. Doan HT, Quan LH, Nguyen TT. The effectiveness of transdermal testosterone gel 1% (androgel) for poor responders undergoing in vitro fertilization. Gynecological Endocrinology. 2017; 33 (12):977-979. doi:10.1080/ 09513590.2017.1332586
6. Vương Thị Ngọc Lan. Kích thích buồng trứng và các tác động lên kết quả kỹ thuật hỗ trợ sinh sản. In: Thụ Tinh Trong Ống Nghiệm. NXB Giáo Dục Việt Nam; 2011:343-372.
7. Nguyễn Việt Hà. Hiệu quả của testosterone dạng gel trên các bệnh nhân thụ tinh trong ống nghiệm giảm dự trữ buồng trứng. Trường Đại học Y Hà Nội; 2017.
8. Balasch J, Fábregues F, Peñarrubia J, et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Human Reproduction. 2006;21(7):1884-1893. doi:10.1093/humrep/del052